comparemela.com

Latest Breaking News On - Platform licensees - Page 6 : comparemela.com

REGENXBIO to Host Conference Call on August 2 to Discuss Second Quarter 2023 Financial Results and Recent Operational Highlights

/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Wednesday, August 2, 2023, at 4:30 p.m. ET to discuss its.

Chris brinzeyTechnology platform licenseesTechnology platformPlatform licenseesRegenxbio inc

REGENXBIO Announces Upcoming Presentations at the American Society of Retina Specialists Annual Scientific Meeting

ROCKVILLE - REGENXBIO Inc. today announced three presentations at the American Society of Retina Specialists Annual Scientific Meeting, taking place in Seattle, Washington from July 28 through.

United statesAshkanm abbeyDavids boyerDilshers dhootChris brinzeyAmerican societyClinical researchUt southwestern medical centerTechnology platform licenseesTexas retina associatesVitreous associates medical groupTechnology platformSubretinal deliveryRetina associatesClinical assistant professorSuprachoroidal delivery

REGENXBIO Announces Upcoming Presentations at the American Society of Retina Specialists Annual Scientific Meeting

/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced three presentations at the American Society of Retina Specialists (ASRS) Annual Scientific.

United statesDavids boyerDilshers dhootChris brinzeyAshkanm abbeyClinical research at texas retina associatesVitreous associates medical groupTechnology platformAmerican society of retina specialistsUt southwestern medical centerTechnology platform licenseesAmerican societyRetina specialistsAnnual scientific meetingSubretinal deliveryClinical research

REGENXBIO Highlights AAV Pipeline with Interim Results from Retinal and Duchenne Programs at its Virtual Investor Day on July 11, 2023

-Interim results from Phase II AAVIATE and ALTITUDE trials of dose level 3 cohorts with short-course prophylactic steroid eye drops resulted in zero cases of.

United statesChris brinzeyWorld muscle societyTechnology platformWorld muscle society congressSecurities exchangeExchange commissionTechnology platform licenseesDuchenne programRetinal programAmerican academy of ophthalmologyManufacturing innovation centerExon skipping programVirtual investor dayInvestor dayChief executive officer

REGENXBIO to Host Virtual Investor Day Highlighting AAV Pipeline Programs with Upcoming Interim Trial Updates

/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a virtual investor day on July 11, 2023. During the event, members of.

United statesVeeral shethGeorge dicksonPeter kaiserChris brinzeySecurities exchangeOphthalmology researchCleveland clinic lerner college of medicineMacula associatesTechnology platformManufacturing innovation centerExchange commissionUniversity of londonTechnology platform licenseesPartner at university retinaDiabetic retinopathy

vimarsana © 2020. All Rights Reserved.